NCT01675518View on ClinicalTrials.gov

A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
HealthyPharmacokinetics of ASP7991
Interventions
DRUG

ASP7991

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY